HC Wainwright & Co. Downgrades Bionomics to Neutral

HC Wainwright & Co. analyst Joseph Pantginis downgrades Bionomics (NASDAQ:BNOX) from Buy to Neutral.

HC Wainwright & Co. analyst Joseph Pantginis downgrades Bionomics (NASDAQ:BNOX) from Buy to Neutral.

Total
0
Shares
Related Posts
Read More

SolarEdge Stock Plummets After Mixed Q4 Results

SolarEdge Technologies reported quarterly losses of 92 cents per share which beat the analyst consensus estimate of losses of $1.33 by 30.83%. The company reported quarterly sales of $316 million, missing the analyst consensus estimate of $323.3 million by 2.26% and representing a 64.52% decrease over sales of $890.7 million from the same period last year.

SEDG